These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6228191)

  • 1. Antibacterial activity of norfloxacin in the gastrointestinal tracts of rats.
    Frimodt-Møller PC; Jensen KM; Madsen PO
    Antimicrob Agents Chemother; 1983 Oct; 24(4):560-3. PubMed ID: 6228191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of selective decontamination of the gi-tract of mice on the survival of intestinal mucosa during X-irradiation.
    Toorop-Bouma AG; Van der Waaij D
    Prog Clin Biol Res; 1985; 181():271-3. PubMed ID: 3161088
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro antibacterial activity of norfloxacin (MK-0366, AM-715) and other agents against gastrointestinal tract pathogens.
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):86-90. PubMed ID: 6219622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective decontamination of the digestive tract by norfloxacin. A preliminary report.
    Pecquet SS; Andremont AO; Tancrède CH
    Prog Clin Biol Res; 1985; 181():255-8. PubMed ID: 3161086
    [No Abstract]   [Full Text] [Related]  

  • 5. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
    Corrado ML; Cherubin CE; Shulman M
    J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.
    Seibert G; Limbert M; Klesel N
    Eur J Clin Microbiol; 1983 Dec; 2(6):548-53. PubMed ID: 6230226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Petermüller C
    Eur J Clin Microbiol; 1983 Apr; 2(2):111-5. PubMed ID: 6222896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
    Fromtling RA; Abruzzo GK; Gadebusch HH
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of appearance of resistant variants to norfloxacin and nalidixic acid.
    Duckworth GJ; Williams JD
    J Antimicrob Chemother; 1984 May; 13 Suppl B():33-8. PubMed ID: 6234273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of norfloxacin (MK-0366) and ten other oral antimicrobial agents against urinary bacterial isolates.
    Khan MY; Gruninger RP; Nelson SM; Klicker RE
    Antimicrob Agents Chemother; 1982 May; 21(5):848-51. PubMed ID: 6213200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Norfloxacin for selective decontamination: a study in human volunteers.
    De Vries-Hospers HG; Welling GW; Van der Waaij D
    Prog Clin Biol Res; 1985; 181():259-62. PubMed ID: 3161087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
    Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
    J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-vitro activity of enoxacin, ofloxacin, norfloxacin and nalidixic acid.
    Bauernfeind A; Ullmann U
    J Antimicrob Chemother; 1984 Sep; 14 Suppl C():33-8. PubMed ID: 6238931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norfloxacin--a new antibacterial agent with anti-pseudomonal activity.
    Peddie BA
    N Z Med J; 1982 Oct; 95(717):712. PubMed ID: 6216426
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro antibacterial action of norfloxacin].
    Fabio U; Provvisionato CA; Tampieri A; Quaglio GP
    G Ital Chemioter; 1983; 30(1):53-9. PubMed ID: 6229443
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative activities of ciprofloxacin (Bay o 9867), norfloxacin, pipemidic acid, and nalidixic acid.
    Muytjens HL; van der Ros-van de Repe J; van Veldhuizen G
    Antimicrob Agents Chemother; 1983 Aug; 24(2):302-4. PubMed ID: 6227281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
    Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
    Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial activity of norfloxacin (MK-0366).
    King A; Warren C; Shannon K; Phillips I
    Antimicrob Agents Chemother; 1982 Apr; 21(4):604-7. PubMed ID: 6211139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of norfloxacin.
    Norrby SR; Jonsson M
    Antimicrob Agents Chemother; 1983 Jan; 23(1):15-8. PubMed ID: 6219617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.